Prognostic significance of invasive cribriform gland size and percentage in Gleason score 7 prostate adenocarcinoma.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
Emel Tekin, Nazlı Sena Şeker, Ata Özen, Mustafa Fuat Açıkalın, Cavit Can, Ertuğrul Çolak
{"title":"Prognostic significance of invasive cribriform gland size and percentage in Gleason score 7 prostate adenocarcinoma.","authors":"Emel Tekin, Nazlı Sena Şeker, Ata Özen, Mustafa Fuat Açıkalın, Cavit Can, Ertuğrul Çolak","doi":"10.1093/ajcp/aqae082","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Cribriform glands are linked to poorer outcomes in prostate adenocarcinoma. We aimed to assess the prognostic role of the percentage of cribriform glands and the size of the largest invasive cribriform gland in Gleason score 7 prostate adenocarcinomas.</p><p><strong>Methods: </strong>The presence, percentage, and size of the invasive cribriform glands were investigated and their association with prognostic factors were assessed in 177 Grade Groups 2 and 3 prostate adenocarcinomas.</p><p><strong>Results: </strong>Biochemical recurrence-free survival was statistically significantly lower in cases with a cribriform gland percentage greater than 10% (P < .001) and in cases where the largest invasive cribriform gland size was greater than 0.5 mm (P < .001). Mean largest cribriform gland size and percentage were statistically significant associated with more advanced pT status, lymph node metastasis, biochemical recurrence, and higher preoperative prostate-specific antigen values.</p><p><strong>Conclusions: </strong>Our findings suggest that the presence of a cribriform pattern, increases in the percentage of such patterns, and increases in the size of the largest cribriform gland within a given tumor are associated with poor prognosis. We suggest that a more aggressive clinical approach may be needed in Grade Group 2 and 3 cases with invasive cribriform glands larger than 0.5 mm and a cribriform gland percentage greater than 10%, especially in prostate needle biopsy specimens.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ajcp/aqae082","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Cribriform glands are linked to poorer outcomes in prostate adenocarcinoma. We aimed to assess the prognostic role of the percentage of cribriform glands and the size of the largest invasive cribriform gland in Gleason score 7 prostate adenocarcinomas.

Methods: The presence, percentage, and size of the invasive cribriform glands were investigated and their association with prognostic factors were assessed in 177 Grade Groups 2 and 3 prostate adenocarcinomas.

Results: Biochemical recurrence-free survival was statistically significantly lower in cases with a cribriform gland percentage greater than 10% (P < .001) and in cases where the largest invasive cribriform gland size was greater than 0.5 mm (P < .001). Mean largest cribriform gland size and percentage were statistically significant associated with more advanced pT status, lymph node metastasis, biochemical recurrence, and higher preoperative prostate-specific antigen values.

Conclusions: Our findings suggest that the presence of a cribriform pattern, increases in the percentage of such patterns, and increases in the size of the largest cribriform gland within a given tumor are associated with poor prognosis. We suggest that a more aggressive clinical approach may be needed in Grade Group 2 and 3 cases with invasive cribriform glands larger than 0.5 mm and a cribriform gland percentage greater than 10%, especially in prostate needle biopsy specimens.

格里森评分 7 级前列腺癌中浸润性楔形腺大小和百分比的预后意义。
目的:楔形腺与前列腺腺癌较差的预后有关。我们旨在评估格里森评分 7 分前列腺腺癌中楔形腺的比例和最大浸润性楔形腺的大小对预后的作用:方法:在177例2级和3级前列腺腺癌中调查了浸润性楔形腺的存在、百分比和大小,并评估了它们与预后因素的关系:结果:楔形腺比例大于 10%的病例的无生化复发生存率在统计学上明显较低(P 结论:楔形腺比例大于 10%的病例的无生化复发生存率在统计学上明显较低(P):我们的研究结果表明,楔形腺的存在、楔形腺比例的增加以及特定肿瘤中最大楔形腺大小的增加与预后不良有关。我们认为,对于侵袭性楔形腺大于 0.5 毫米且楔形腺比例大于 10%的 2 级和 3 级病例,尤其是前列腺针刺活检标本,可能需要采取更积极的临床治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信